Evidence map›Paper›PMID 27034743›Full record

ArticleOxidative medicine and cellular longevity2016

Differential Mitochondrial Adaptation in Primary Vascular Smooth Muscle Cells from a Diabetic Rat Model.

Amy C Keller, Leslie A Knaub, P Mason McClatchey, Chelsea A Connon, Ron Bouchard, Matthew W Miller, Kate E Geary, Lori A Walker, Dwight J Klemm, Jane E B Reusch

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Oxidative Regulation of Vascular CaAntioxidants (Basel, Switzerland) · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Amy C KellerDivision of Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Medicine, Denver VA Medical Center, Denver, CO 80220, USA.
Leslie A KnaubDivision of Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Medicine, Denver VA Medical Center, Denver, CO 80220, USA.
P Mason McClatcheyDivision of Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Medicine, Denver VA Medical Center, Denver, CO 80220, USA; Department of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Chelsea A ConnonDivision of Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Medicine, Denver VA Medical Center, Denver, CO 80220, USA.
Ron BouchardDepartment of Medicine, Denver VA Medical Center, Denver, CO 80220, USA.
Matthew W MillerDivision of Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Medicine, Denver VA Medical Center, Denver, CO 80220, USA.
Kate E GearyDivision of Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Medicine, Denver VA Medical Center, Denver, CO 80220, USA.
Lori A WalkerDepartment of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Dwight J KlemmDivision of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Jane E B ReuschDivision of Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Medicine, Denver VA Medical Center, Denver, CO 80220, USA; Center for Women's Health Research, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Denver VA Medical Center · USUniversity of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Wendy M Kohrt · 1995 to 2026
$32.6M
Translational Pulmonary Vascular Biology ProgramT32HL007171 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Sonia Castro Flores, Tim Lahm · 1985 to 2026
$9.4M
Targeting Microvascular Contributors to Impaired Functional Exercise Capacity in DiabetesI01BX002046 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI REUSCH, JANE E · 2014 to 2024
–
BLRD VA I01 BX002046NCI NIH HHS P30 CA046934NCI NIH HHS P30CA046934NCRR NIH HHS UL1 RR025780NCRR NIH HHS UL1RR025780NHLBI NIH HHS 5P01HL014985NHLBI NIH HHS 5T32HL007171NHLBI NIH HHS P01 HL014985NHLBI NIH HHS T32 HL007171
6 · The paper itself

Abstract

Diabetes affects more than 330 million people worldwide and causes elevated cardiovascular disease risk. Mitochondria are critical for vascular function, generate cellular reactive oxygen species (ROS), and are perturbed by diabetes, representing a novel target for therapeutics. We hypothesized that adaptive mitochondrial plasticity in response to nutrient stress would be impaired in diabetes cellular physiology via a nitric oxide synthase- (NOS-) mediated decrease in mitochondrial function. Primary smooth muscle cells (SMCs) from aorta of the nonobese, insulin resistant rat diabetes model Goto-Kakizaki (GK) and the Wistar control rat were exposed to high glucose (25 mM). At baseline, significantly greater nitric oxide evolution, ROS production, and respiratory control ratio (RCR) were observed in GK SMCs. Upon exposure to high glucose, expression of phosphorylated eNOS, uncoupled respiration, and expression of mitochondrial complexes I, II, III, and V were significantly decreased in GK SMCs (p < 0.05). Mitochondrial superoxide increased with high glucose in Wistar SMCs (p < 0.05) with no change in the GK beyond elevated baseline concentrations. Baseline comparisons show persistent metabolic perturbations in a diabetes phenotype. Overall, nutrient stress in GK SMCs caused a persistent decline in eNOS and mitochondrial function and disrupted mitochondrial plasticity, illustrating eNOS and mitochondria as potential therapeutic targets.

Indexed as

Adaptation, PhysiologicalAnimalsDiabetes Mellitus, ExperimentalMaleMitochondria, MuscleMuscle, Smooth, VascularMyocytes, Smooth MuscleNitric OxideRatsRats, WistarSuperoxidesNitric OxideSuperoxides

Identifiers

PMID27034743
PMCPMC4737048
OpenAlexW2233073998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.